Detalhe da pesquisa
1.
Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.
J Biol Chem
; 286(25): 22665-77, 2011 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21536666
2.
Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice.
Proc Natl Acad Sci U S A
; 105(44): 17109-14, 2008 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957535
3.
Level of macrophage uPA expression is an important determinant of atherosclerotic lesion growth in Apoe-/- mice.
Arterioscler Thromb Vasc Biol
; 29(11): 1737-44, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19729604
4.
Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
Circ Res
; 95(6): 637-44, 2004 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-15297377
5.
Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
Circulation
; 109(17): 2129-35, 2004 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15096455
6.
Regulated transgene expression in vascular smooth muscle.
Circ Res
; 97(8): e85; author reply e85-7, 2005 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16224071
7.
In vivo expression of a conditional TGF-beta1 transgene: no evidence for TGF-beta1 transgene expression in SM22alpha-tTA transgenic mice.
J Mol Cell Cardiol
; 40(1): 148-56, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16288910